News – Page 1022 – Endpoints News

Roche bags full control of Foundation Medicine in $2.4B follow-up buyout

7 years ago

Valeant nosedives on CRL for plaque psoriasis, raising concerns over touted $1B pipeline

7 years ago

High-profile Chinese investor Vincent Cheung plays a lead role in raising $100M round for a Boston start-up

7 years ago

Spinraza rival? With DMD flops in the rearview mirror, PTC Therapeutics posts strong SMA data

7 years ago

Seven biotech IPOs ready to roll; Celltrion's Herceptin biosim gets second review at FDA

7 years ago

Johns Hopkins spinout WindMIL grabs $32.5M to fuel its work on a next-gen approach to cell therapy

7 years ago

Ziopharm gets hit with a clinical hold as FDA red lights human study using their fast-built CAR-T

7 years ago

From top analyst to CFO: Cowen’s Eric Schmidt leaps into the top ranks of biotech’s latest overnight sensation

7 years ago

Catalyst Bio shares bashed as neutralizing antibodies force investigators to freeze hemophilia cohort work

7 years ago

Solid Bio is back in business after the FDA lifts clinical hold on Duchenne MD gene therapy

7 years ago

After a crushing PhIII failure, Cytokinetics says its next-gen muscle drug is lining up well in PhII — but big ...

7 years ago

Daiichi says it’s ready to change the standard of care for acute myeloid leukemia — but it’s a work in progress

7 years ago

Former biotech analyst Jason Napodano sentenced to a short stretch in a federal prison for securities fraud

7 years ago

Winners and losers at #EHA18: Shares mostly slide as data from a range of prominent biotechs fail to wow investors

7 years ago

Aimmune signs Jayson Dallas on to succeed retiring CEO; Eduardo Bravo leaves TiGenix in final chapter of Takeda ...

7 years ago

Teva hit by another PhIII setback on CGRP pain drug fremanezumab, but there’s no pulling back now as rivals race ...

7 years ago

A functional HIV cure? We have a long way to go, but Hong Kong investigators find a spotlight for their preclinical ...

7 years ago

Verrica Pharma bankrolls PhIII with a $75M IPO raise for lead skin drug

7 years ago

Bristol-Myers wins the frenzied race to a first approval for a PD-1/L1 checkpoint in China as regulators hustle up a ...

7 years ago

In the glare of an intense gene therapy spotlight, bluebird continues to tout each small step forward for its ...

7 years ago

Sanofi sells manufacturing site to Recipharm; Aptose buys rights to sell CrystalGenomics' cancer drug in China

7 years ago

Researchers outline another big disease target for Novartis’ canakinumab as drug slashes rate of gout flares

7 years ago

GSK, ViiV offer sneak peek of PhIII data on in-house two-drug HIV combo, touting non-inferiority

7 years ago

Nightstar's drug for rare vision loss admitted to FDA's gene therapy speedway

7 years ago

First page Previous page 1019 1020 102110221023 1024 1025 Next page Last page